Boston Scientific
888 hedge funds and large institutions have $54.6B invested in Boston Scientific in 2021 Q4 according to their latest regulatory filings, with 121 funds opening new positions, 290 increasing their positions, 322 reducing their positions, and 95 closing their positions.
27% more first-time investments, than exits
New positions opened: 121 | Existing positions closed: 95
1% more funds holding
Funds holding: 877 → 888 (+11)
3% less capital invested
Capital invested by funds: $56.3B → $54.6B (-$1.66B)
10% less repeat investments, than reductions
Existing positions increased: 290 | Existing positions reduced: 322
1.09% less ownership
Funds ownership: 91.5% → 90.41% (-1.1%)
18% less funds holding in top 10
Funds holding in top 10: 11 → 9 (-2)
42% less call options, than puts
Call options by funds: $271M | Put options by funds: $467M
Top Buyers
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
+$508M |
| 2 |
JP Morgan Chase
New York
|
+$396M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$227M |
| 4 |
BlackRock
New York
|
+$126M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$118M |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$391M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$365M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$365M |
| 4 |
Citigroup
New York
|
-$211M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$166M |
BSX Hedge Fund Activity: Q4 2021 in Review
888 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q4 2021, worth a combined $54.6B — down 3% from $56.3B a quarter earlier.
Buyers outnumbered sellers: 121 funds opened new BSX positions and 95 closed out — a net gain of 26 holders — while 290 added to existing stakes and 322 trimmed.
The largest buyer was Viking Global Investors, adding an estimated $508M. The largest seller was Wellington Management Group, cutting an estimated $391M.
- 888 institutional investors held Boston Scientific (BSX) as of Q4 2021, up from 877 in Q3 2021.
- Funds reported $54.6B of Boston Scientific stock for Q4 2021, down 3% quarter-over-quarter.
- 121 funds opened new Boston Scientific positions in Q4 2021 and 95 closed out, a net change of +26 holders.
- The largest Boston Scientific buyer in Q4 2021 was Viking Global Investors, an estimated $508M added.
- The largest Boston Scientific seller in Q4 2021 was Wellington Management Group, an estimated $391M sold.
Based on aggregated 13F filings for Q4 2021.